Anthropic Eyes a $2 Trillion Valuation as Oura Chases Its Own Mega-Round

Two fundraising pushes now define the outer edge of technology valuations: Anthropic is reportedly preparing an initial public offering that would raise about 139 trillion won — on the order of $100 billion — at a valuation of up to $2 trillion, while smart-ring maker Oura is pursuing a round of up to 4 trillion won at a targeted valuation of 22 trillion won, roughly $16 billion. One deal would rewrite the record books for public listings; the other shows that even outside AI’s center of gravity, capital is still being raised at a scale that would have counted as extraordinary only a few years ago.

An IPO Bigger Than Any Before It

The reported terms of Anthropic’s offering are without precedent. A raise of around 139 trillion won from a single listing would far exceed anything public markets have absorbed from one debut to date, and a $2 trillion valuation would place the AI developer alongside the small group of the world’s most valuable listed companies from day one — a threshold that took the current members of that club decades of compounding to reach.

The logic behind an offering of that size is the same one driving the broader AI buildout: frontier model development consumes capital on infrastructure — computing clusters, data centers, power — at a pace that private funding rounds increasingly strain to match. A listing of this scale would effectively ask public investors to underwrite the next phase of that buildout directly. The plans remain at the pursuit stage, and both the raise and the valuation are reported as upper bounds rather than settled terms.

The Ring on the Other Hand

Oura’s reported round is modest only by comparison. The Finnish health-tech company, known for a ring-shaped sleep and health tracker sold with a subscription service, is seeking as much as 4 trillion won against a 22 trillion won target valuation. For a consumer hardware firm — a category that investors spent much of the past decade avoiding — commanding a price in that range signals that recurring health data revenue, not the device itself, is what the money is buying.

Reading the Two Numbers Together

Set side by side, the deals measure how sharply capital has stratified. Anthropic’s intended raise alone is roughly thirty-five times Oura’s entire round, and the valuation gap between the two companies exceeds a hundredfold. A successful consumer platform now operates two orders of magnitude below a frontier AI lab — not because the former got smaller, but because AI has reset the ceiling.

For investors, the two offerings pose different questions. Oura’s round is a conventional late-stage bet on a category leader. Anthropic’s listing, if the reported terms hold, would test something newer: whether public markets can absorb a $100 billion-class offering without strain, and what index inclusion and liquidity look like when a company arrives already valued like a decades-old giant.